Showing results (951-960 of 1,984) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|May 16, 2017
Neurological consequences of obesityPhillipe D O'Brien, Lucy M Hinder, Brian C Callaghan, et al.The Lancet. Neurology|June 11, 2017
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trialDennis Chan, Sophie Binks, Jennifer M Nicholas, et al.The Lancet. Neurology|June 24, 2017
Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trialSeth F Oliveria, Ramon L Rodriguez, Dawn Bowers, et al.The Lancet. Neurology|December 1, 2009
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial managementKatharine Bushby, Richard Finkel, David J Birnkrant, et al.The Lancet. Neurology|December 5, 2009
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trialMarten Munneke, Maarten J Nijkrake, Samyra Hj Keus, et al.The Lancet. Neurology|August 30, 2016
Sudden unexpected death in epilepsy: epidemiology, mechanisms, and preventionOrrin Devinsky, Dale C Hesdorffer, David J Thurman, et al.The Lancet. Neurology|August 30, 2016
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunitiesRichard Macrez, Peter K Stys, Denis Vivien, et al.The Lancet. Neurology|April 25, 2018
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trialSonoko Misawa, Satoshi Kuwabara, Yasunori Sato, et al.The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.The Lancet. Neurology|February 17, 2015
Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial, Hugh S Markus, Elizabeth Hayter, et al.Pageof 199